Research output per year
Research output per year
Fingerprint
Dive into the research topics where Kishore B Challagundla is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
-
Exosomic microRNAs and drug resistance in AML tumor microenvironment
Challagundla, K. B. (PI)
Project: Research project
-
Exosomic microRNAs and drug resistance in AML tumor microenvironment
Challagundla, K. B. (PI)
Project: Research project
-
SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma
Prathipati, P., Pathania, A. S., Chaturvedi, N. K., Gupta, S. C., Byrareddy, S. N., Coulter, D. W. & Challagundla, K. B., Jun 11 2024, In: Molecular Therapy Nucleic Acids. 35, 2, 101543.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma
Pathania, A. S., Chava, H., Chaturvedi, N. K., Chava, S., Byrareddy, S. N., Coulter, D. W. & Challagundla, K. B., Jun 2024, In: Cell Death and Disease. 15, 6, 428.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets
Katta, S. S., Nagati, V., Paturi, A. S. V., Murakonda, S. P., Murakonda, A. B., Pandey, M. K., Gupta, S. C., Pasupulati, A. K. & Challagundla, K. B., May 2023, In: Journal of Controlled Release. 357, p. 444-459 16 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment
Elbezanti, W. O., Challagundla, K. B., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M. K., Mar 2023, In: Pharmaceuticals. 16, 3, 415.Research output: Contribution to journal › Review article › peer-review
Open Access9 Scopus citations -
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
Kling, M. J., Kesherwani, V., Mishra, N. K., Alexander, G., McIntyre, E. M., Ray, S., Challagundla, K. B., Joshi, S. S., Coulter, D. W. & Chaturvedi, N. K., Dec 2022, In: Journal of Experimental and Clinical Cancer Research. 41, 1, 321.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations